The National Institute of Neurological Disorders and Stroke (NINDS) encourages grant applications for research on the pathogenesis and therapies for muscular dystrophy. This announcement is made together with 3 other components of the National Institutes of Health (NIH).
Muscular dystrophies—which are characterized by progressive weakness and wasting of muscles—collectively have a high impact on health, affecting tens of thousands of people in the United States alone. Many cases of muscular dystrophy represent new occurrences of disease, where there is no prior family history. Though recent research has increased knowledge about genetic defects associated with many forms of muscular dystrophy, there has not been a corresponding improvement in treatment of these diseases. There is a need to learn more about the pathogenesis of the diseases and to improve early detection, diagnosis, treatment, and prevention.
For more information, potential applicants should contact Dr. John Porter, Program Director, Channels, Synapses, and Circuits Cluster, NINDS; telephone: 301-496-1917; e-mail: email@example.com. For a more detailed description of this announcement, visit http://grants.nih.gov/grants/guide/pa-files/PA-07-125.html.